Donald Sikazwe

Donald Sikazwe is a Professor of Pharmaceutical Sciences at the Feik School of Pharmacy, University of the Incarnate Word (UIW). His academic and professional journey spans multiple institutions, including Schering-Plough Inc., Virginia Commonwealth University (VCU), Roskamp Research Institute, and Archer Pharmaceuticals Inc.

• B.S. in Chemistry (1990), Edward Waters College
• M.S. in Pharmacy (1996), University of Florida
• Ph.D. in Pharmaceutical Sciences (2004), Florida A&M University

Dr. Sikazwe's research focuses on Central Nervous System (CNS) drug discovery, particularly the design and synthesis of anti-neurodegenerative agents. His work has involved cross-disciplinary collaborations and industrial partnerships, addressing conditions such as Schizophrenia and Alzheimer's disease.

• Kirschstein-NRSA Postdoctoral Fellowship at VCU
• Contributions to two patents for D2/D4 anti-dopaminergics in Schizophrenia research

He teaches Medicinal Chemistry and Pharmacotherapeutics courses at UIW-Feik School of Pharmacy, covering CNS, dermatological, ear/eye/nose/throat (DEENT), and Pulmonary domains. His professional memberships include the American Chemical Society (ACS), American Association of Colleges of Pharmacy (AAPS), Rho Chi Honor Society, and American Association of Pharmaceutical Scientists (AAPS).

Dr. Sikazwe has held laboratory supervisory roles at Archer Pharmaceuticals Inc. and participated in exploratory chemistry projects. His career bridges academia, industry, and research institutes, emphasizing innovative drug development and mentorship in pharmaceutical sciences.